Question 1

What is HCPCS code Q5120?

Accepted Answer

HCPCS code Q5120 is "Inj pegfilgrastim-bmez 0.5mg". Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg

Question 2

What category is Q5120 in?

Accepted Answer

Q5120 belongs to HCPCS Category Q (Temporary Codes).

Question 3

When should I use HCPCS code Q5120?

Accepted Answer

Use Q5120 when billing for inj pegfilgrastim-bmez 0.5mg. HCPCS Level II codes like this are used for items and services not covered by CPT codes, including medical supplies, equipment, drugs administered in clinical settings, and certain healthcare services.

Question 4

What ICD-10 codes are commonly used with Q5120?

Accepted Answer

Common ICD-10 diagnosis codes used with Q5120 include: B20 (Human immunodeficiency virus [HIV] disease), C00.0 (Malignant neoplasm of external upper lip), C00.1 (Malignant neoplasm of external lower lip), C00.2 (Malignant neoplasm of external lip, unspecified). Always ensure proper medical documentation supports the medical necessity for the HCPCS code being billed.

Question 5

Is Q5120 covered by Medicare?

Accepted Answer

Coverage for Q5120 (Inj pegfilgrastim-bmez 0.5mg) depends on medical necessity and specific Medicare guidelines. Check the applicable Local Coverage Determination (LCD) or National Coverage Determination (NCD) for detailed coverage criteria. Private insurers may have different coverage policies.

Question 6

What documentation is required for Q5120?

Accepted Answer

Documentation for Q5120 should include: the medical necessity for the item or service, supporting diagnosis codes (ICD-10), prescription or order from the treating physician, and proof that the item meets quality standards. Some items may require additional documentation like a Certificate of Medical Necessity (CMN).